[The Biological Activity of the Sevanol and Its Analogues]
Bioorganicheskaia Khimiia
|January 15, 2016
Summary
Sevanol, a natural compound, effectively inhibits the acid-sensing ion channel 3 (ASIC3) and reduces pain and inflammation. Synthetic analogs show similar activity, highlighting the importance of molecular structure for drug development.
Area of Science:
- Pharmacology
- Neuroscience
- Organic Chemistry
Context:
- The natural lignan sevanol, isolated from Thymus armeniacus, demonstrates potent inhibition of acid-sensing ion channel 3 (ASIC3).
- This inhibition correlates with significant analgesic and anti-inflammatory effects.
- Understanding the structure-activity relationship of sevanol is crucial for developing novel therapeutics.
Purpose:
- To evaluate the biological activity of synthetic analogs of sevanol.
- To compare the inhibitory effects of a sevanol stereoisomer and a precursor molecule on human ASIC3 channels.
- To elucidate the role of specific functional groups and spatial configuration in sevanol's bioactivity.
Summary:
- Electrophysiological experiments were conducted on human ASIC3 channels expressed in Xenopus laevis oocytes.
- A chemically synthesized sevanol analog exhibited inhibitory activity comparable to the natural compound.
- A stereoisomer showed a reduced inhibitory effect (approx. 33% decrease), while a precursor molecule displayed significantly lower activity.
Impact:
- The study confirms the importance of sevanol's specific functional groups and stereochemistry for its biological activity.
- Findings provide valuable insights for optimizing the synthesis of sevanol analogs.
- This research lays the groundwork for designing new drugs based on the sevanol scaffold for pain and inflammation management.
More Related Videos
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
01:30Local Anesthetics: Chemistry and Structure-Activity Relationship
7.1K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
7.1K
01:25Bioactivation and Tissue Toxicity
107
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
107
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.5K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.5K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
3.0K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.0K